RU-2309

RU-2309
Clinical data
Other names	18-Methylmetribolone; 17α-Methyltetrahydrogestrinone; 17α-Methyl-THG; ∆9,11-17α,18-dimethyl-19-nortestosterone; 17α,18-Dimethylestr-4,9,11-trien-17β-ol-3-one
Drug class	Androgen; Anabolic steroid
Identifiers
	IUPAC name (8S,13S,14S,17S)-13-ethyl-17-hydroxy-17-methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;
JSmol)	Interactive image;
	SMILES CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C)O;
	InChI InChI=1S/C20H26O2/c1-3-20-11-8-16-15-7-5-14(21)12-13(15)4-6-17(16)18(20)9-10-19(20,2)22/h8,11-12,17-18,22H,3-7,9-10H2,1-2H3/t17-,18+,19+,20+/m1/s1; Key:KTIKZXSPPAGDBN-FYQPLNBISA-N;

RU-2309, also known as 18-methylmetribolone, δ^9,11-17α,18-dimethyl-19-nortestosterone, or 17α,18-dimethylestr-4,9,11-trien-17β-ol-3-one, is a

affinity for the androgen, progesterone, and glucocorticoid receptors.^[1]^[2]^[3]

References

^
PMID 7382482
.

^
PMID 359134
.

^
S2CID 22004130
.

^
ISBN 978-0-16-090721-0
.

[pmid7382482-1] 
PMID 7382482
.

[pmid359134-2] 
PMID 359134
.

[pmid1291626-3] 
S2CID 22004130
.

[Office2012-4] 
ISBN 978-0-16-090721-0
.

[1]

[2]

[3]

See also

References